Found: 17
Select item for more details and to access through your institution.
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Evolution of Abeta42 and Abeta40 Levels and Abeta42/Abeta40 Ratio in Plasma during Progression of Alzheimer's Disease: A Multicenter Assessment.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Evolution of Aβ42 and Aβ40 levels and Aβ42/Aβ40 ratio in plasma during progression of Alzheimer’s disease: A multicenter assessment.
- Published in:
- Journal of Nutrition, Health & Aging, 2009, v. 13, n. 3, p. 205, doi. 10.1007/s12603-009-0059-0
- By:
- Publication type:
- Article
Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
- Published in:
- Journal of Neuroscience Research, 2003, v. 72, n. 4, p. 520, doi. 10.1002/jnr.10599
- By:
- Publication type:
- Article
The effect of simvastin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
The Effect of Simvastatin Treatment on the Amyloid Precursor Protein and Brain Cholesterol Metabolism in Patients with Alzheimer’s Disease.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2005, v. 19, n. 5/6, p. 256, doi. 10.1159/000084550
- By:
- Publication type:
- Article
Unaltered Plasma Levels of β-Amyloid<sub>(140)</sub> and β-Amyloid<sub>(142)</sub> upon Stimulation of Human Platelets.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2003, v. 16, n. 2, p. 93, doi. 10.1159/000070681
- By:
- Publication type:
- Article
Cerebrospinal Fluid Beta-Amyloid 42 Is Reduced before the Onset of Sporadic Dementia: A Population-Based Study in 85-Year-Olds.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2003, v. 15, n. 3, p. 169, doi. 10.1159/000068478
- By:
- Publication type:
- Article
Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia.
- Published in:
- Acta Anaesthesiologica Scandinavica, 2011, v. 55, n. 9, p. 1132, doi. 10.1111/j.1399-6576.2011.02505.x
- By:
- Publication type:
- Article
Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis.
- Published in:
- Neuropathology & Applied Neurobiology, 2006, v. 32, n. 3, p. 318, doi. 10.1111/j.1365-2990.2006.00730.x
- By:
- Publication type:
- Article
No association of CSF biomarkers with APOE4, plaque and tangle burden in definite Alzheimer's disease.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
- Published in:
- Molecular Psychiatry, 2003, v. 8, n. 3, p. 343, doi. 10.1038/sj.mp.4001220
- By:
- Publication type:
- Article
MICROGLIA-DEPENDENT NEURODEGENERATION: AN IN VITRO MODEL.
- Published in:
- 1999
- By:
- Publication type:
- Abstract
CSF levels of tau, β-amyloid<sub>1–42</sub> and GAP-43 in frontotemporal dementia, other types of dementia and normal aging.
- Published in:
- Journal of Neural Transmission, 2000, v. 107, n. 5, p. 563
- By:
- Publication type:
- Article